Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
CPI-006 is a monoclonal antibody against NT5E (CD73) that inhibits the conversion of AMP to adenosine to inhibit tumor growth and also has immunomodulatory activities (Journal of Clinical Oncology 2019 37:15_suppl, TPS2646).
|DrugClasses||Adenosine Targeting 19 CD73 Antibody 10|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|CPI-006 + CPI-444||CPI-006 CPI-444||0||1|
|CPI-006 + Pembrolizumab||CPI-006 Pembrolizumab||0||1|